Soft Reboot Wellness has announced that they are offering their IV ketamine therapy to those suffering from depression in Palo Alto. The innovative treatment offers relief from symptoms where traditional treatment has failed to have a significant effect.
Soft Reboot Wellness announced that it can now provide IV ketamine infusion designed to reduce symptoms and manage conditions associated with treatment-resistant depression.
More details can be found at https://www.softrebootwellness.com/how-does-ketamine-help-where-antidepressants-dont
The recent expansion of the clinic’s IV ketamine therapy to Palo Alto residents comes as depression is recognized globally as the leading cause of disability. Recent estimates show that in excess of 16 million US adults suffered an episode of major depression in the course of a year, increasing the rate of suicide in 25 states by more than 30% (1).
Dr. Sara Herman, MD, founder of Soft Reboot Wellness, administers ketamine through an intravenous (IV) infusion in a calm, safe, clinical setting. The therapy is designed to provide low doses of ketamine which has been proven to calm the mind and offer the brain a chance to ‘reboot’.
A comprehensive resource in response to frequently asked questions about ketamine therapy can be found at https://www.softrebootwellness.com/faqs
Traditional depression treatment operates by inhibiting the reuptake of monoamines such as serotonin, norepinephrine, and dopamine, which helps improve communication between brain cells, explains Soft Reboot Wellness. While effective for most, it can lead to significant side effects, including mood changes. Ketamine therapy, however, restores the neurotransmitter, glutamate, and its receptors which increases the production of brain proteins, thus building stronger connections and reversing the damage to synapses.
The novel way in which ketamine affects the brain means that it can be effective in patients with treatment-resistant depression (TRD).
About Soft Reboot Wellness
Soft Reboot Wellness’s state-of-the-art facility is located in Menlo Park, California, and serves the Silicon Valley and the Bay Area, including San Francisco, Redwood City, Menlo Park, Palo Alto, Mountain View and Burlingame. They provide IV ketamine therapy and support services under the center’s founder Dr. Sara Herman, MD, a Harvard-trained, board-certified anesthesiologist.
Interested parties can find more information on Soft Reboot’s IV ketamine therapy at https://www.softrebootwellness.com/iv_ketamine_therapy_bay_area
(1) Studies cited by Harvard Medical School https://www.health.harvard.edu/blog/ketamine-for-major-depression-new-tool-new-questions-2019052216673